Wellorithm Review
Best for: compounded GLP-1 access with oral tablet options across 49 states
Wellorithm is a Miami-based GLP-1 telehealth offering compounded semaglutide and compounded tirzepatide in both injectable and oral dissolving tablet formats. Available in 49 states (not Louisiana). Board-certified obesity specialists provide virtual consultations with 24/7 support.
Medium confidence · Last verified 2026-04-10 via Chrome MCP live pull · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Wellorithm is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Wellorithm prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
✓ Pros
- •Four compounded GLP-1 formats: semaglutide injectable, semaglutide oral dissolving tablets, tirzepatide injectable, tirzepatide oral dissolving tablets
- •Available in 49 states — broader coverage than most compounded GLP-1 telehealth providers
- •Board-certified obesity specialists with virtual consultations
- •2-minute quiz onboarding — fast async approval path
- •24/7 support with dedicated phone line
- •Katalys RevOffers tracking pixel detected — affiliate program active
✗ Cons
- •Not available in Louisiana
- •Pricing not publicly disclosed on their website — requires completing the intake quiz
- •No visible LegitScript certification or PCAB accreditation
- •Compounded medications have not been reviewed or approved by the FDA (stated on their site)
Ready to start with Wellorithm?
See current pricing and start your free consultation.
Sources & methodology
Our Wellorithm review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Wellorithm
Belle Health
Best for: Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Wellorithm?
See current pricing and start your free consultation.